Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).

Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...

Background Anticoagulation non-adherence is attributed to myriad factors in patient populations across the world. While direct oral anticoagulants (DOACs) have demonstrated several clinical advantages ...

Background Previous studies have suggested an adverse role of epicardial adipose tissue (EAT) in aortic stenosis (AS), ...

Background Patients with heart failure (HF) and severe mitral regurgitation (MR) have poor outcomes. Early identification ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

Introduction Ischaemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide and poses an ...

Background International guidelines recommend percutaneous coronary intervention within 120 min for high-risk acute coronary syndrome. In Indonesia, a sprawling archipelago with a rising ...

APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...

Introduction Infective endocarditis (IE) remains challenging, and culture-negative IE (CNIE) complicates diagnosis by removing microbiological confirmation. Echocardiography is pivotal but can be ...

Introduction Hypertension is a major contributor to cardiovascular morbidity and mortality worldwide. Prolonged elevated blood pressure may cause structural and functional remodeling of the left ...

Introduction Infective endocarditis (IE) is a serious illness often associated with structural heart disease. In young, active servicemen, it is uncommon and can be easily overlooked even when initial ...